Form 4 for BDTX Black Diamond Therapeutics, Inc.
Accepted 2026-03-20 00:00:00 ET · period of report 2026-03-20 · accession 0001193125-26-117938 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-20 | 2026-03-20 | BDTX | Behbahani Ali | Dir | A - Grant | $2.15 | +6,919 | 93.6K | +8% | +$14.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-20 | A | A | 6,919 | $2.15 | 93,568 | D | — | — | (F2) The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on March 19, 2026. |